EU BreathSpec Project
The BreathSpec project aims to develop a rapid, non-invasive device that can diagnose bacterial or viral infections through ultra-high sensitivity breath analysis. Once developed the BreathSpec device will help reduce the development of anti-bacterial resistance and alleviate the growing problem of antimicrobial resistance (AMR) through improved diagnosis of antibiotic treatment. The device will also reduce the scientific, clinical and financial challenges associated with the development of new antibiotics.
More details can be found at: www.breathspec.com
1. To optimise the design and functionality of the existing analytical device for the purpose of breath analysis for microbial volatiles, upgrading sensitivity and selectivity.
2. To undertake multi-centre studies using healthy volunteers and patients with known pathologies to generate characteristic data for the production of algorithms to separate bacterial from viral infections.
3. Undertake field trials to validate the optimised device with input from key stakeholders including full analytical and clinical validation
4. Generate analytical and clinical data to apply for the necessary regulatory approvals.
5. Undertake value engineering and health economics studies to inform the commercialisation process.
6. Initiate commercialisation of the product in target sectors/markets through our distribution channels and effective innovation management and dissemination